Key points are not available for this paper at this time.
INTRODUCTION: Chronic venous disease (CVD) is a common condition associated with valvular dysfunction, venous hypertension and endothelial inflammation. Sulodexide facilitates the healing of venous ulcers and is frequently used in patients with CVD without ulcer. This review assessed the efficacy and safety of sulodexide for treatment of signs and symptoms of lower extremity CVD. METHODS: ). RESULTS: = 0%; 270 participants). The overall risk of AEs with sulodexide was low: 3% (95% CI 1-4%) estimated from 3656 participants. CONCLUSION: Sulodexide was found to have a beneficial venoactive effect on the major signs and symptoms of CVD such as pain, cramps, heaviness and oedema without increasing the risk of AEs. It is also likely to exert a systemic effect on the course of CVD by interfering with inflammatory chemokines.
Building similarity graph...
Analyzing shared references across papers
Loading...
A Bignamini
Jiří Matuška
Advances in Therapy
University of Milan
Building similarity graph...
Analyzing shared references across papers
Loading...
Bignamini et al. (Mon,) studied this question.
www.synapsesocial.com/papers/6a03af232ca770c848de075d — DOI: https://doi.org/10.1007/s12325-020-01232-1